NGM·Healthcare·$1.2B·#55 / 520 in Healthcare
PHAR Pharming Group N.V.
71SOLID
CATEGORY BREAKDOWN
GROWTH42
QUALITY87
STABILITY88
VALUATION89
GOVERNANCE33
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+26.6%
42
> 50% strong
Gross Margin
Revenue retained after direct costs
87.9%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
41.8%
63
< 25% strong
Price / Sales
Market cap relative to trailing revenue
3.1x
89
< 3x strong
Rule of 40
Growth rate plus operating margin
32
68
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
0.0%
0
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-89.7%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE PHAR WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when PHAR's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.